What is Verility?
Verility operates at the forefront of the AgTech sector, specializing in the development of innovative tools designed to optimize breeding and fertility management in animal health. Their flagship product, FERTILE-EYEZ, represents a paradigm shift in the industry by integrating sophisticated image recognition and artificial intelligence into a portable mobile device. This technology streamlines complex processes such as sperm analysis and ovulation detection, effectively removing the barriers of cost and human error that have historically plagued traditional diagnostic methods.
By democratizing access to high-precision fertility assessments, Verility is not merely providing a technical tool but is actively contributing to the stability of the global food supply chain. Their market position is defined by a focus on scalability and user-centric design, ensuring that breeders can achieve higher conception rates with greater efficiency. As the industry faces increasing pressure to improve productivity, Verility's AI-driven approach offers a scalable solution to long-standing biological challenges.
How much funding has Verility raised?
Verility has raised a total of $3.6M across 2 funding rounds:
Series A
$3.5M
Debt
$150K
Series A (2022): $3.5M with participation from Mountain Group Partners
Debt (2026): $150K, investors not publicly disclosed
Key Investors in Verility
Mountain Group Partners
Mountain Group Partners is a Nashville-based venture capital firm that specializes in investing in early-stage companies within the Life Sciences, AgTech, and Technology sectors.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Verility?
With the recent $150K injection, Verility is well-positioned to scale its operational footprint and deepen its research and development capabilities. The strategic focus will likely shift toward expanding the commercial reach of FERTILE-EYEZ, targeting key international markets where livestock management efficiency is a critical economic driver. Furthermore, the company is expected to explore additional applications for its AI-driven diagnostic platform, potentially diversifying its product portfolio within the broader animal health ecosystem.
As Verility moves into this next phase of growth, the emphasis will remain on maintaining technological superiority while navigating the complexities of global agricultural supply chains. The firm's ability to integrate its solutions into existing breeding workflows will be a key determinant of its long-term success and market penetration.
